| Title |
Long‐acting beta2‐agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2007
|
| DOI | 10.1002/14651858.cd001385.pub2 |
| Pubmed ID | |
| Authors |
E. Haydn Walters, Peter G Gibson, Toby J Lasserson, Julia AE Walters |
| Abstract |
Asthma is a common respiratory disease among both adults and children and short acting inhaled beta-2 agonists are used widely for 'reliever' bronchodilator therapy. Long acting beta-2 agonists (LABA) were introduced as prospective 'symptom controllers' in addition to inhaled corticosteroid 'preventer' therapy (ICS). In this updated review we have included studies in which patients were either not on ICS as a group, or in which some patients, but not all, were on ICS to complement previous systematic reviews of studies where LABA was given in patients uniformly receiving ICS. We have focussed particularly on serious adverse events, given previous concerns about potential risks, especially of death, from regular beta-2 agonist use. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Ecuador | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 236 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| Japan | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 231 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 41 | 17% |
| Student > Ph. D. Student | 23 | 10% |
| Researcher | 22 | 9% |
| Student > Bachelor | 20 | 8% |
| Student > Doctoral Student | 13 | 6% |
| Other | 43 | 18% |
| Unknown | 74 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 80 | 34% |
| Nursing and Health Professions | 30 | 13% |
| Unspecified | 10 | 4% |
| Psychology | 8 | 3% |
| Agricultural and Biological Sciences | 7 | 3% |
| Other | 21 | 9% |
| Unknown | 80 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2017.
All research outputs
#4,857,628
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,973
of 11,499 outputs
Outputs of similar age
#21,355
of 173,990 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 69 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,990 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.